These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dexmedetomidine restores autophagy and cardiac dysfunction in rats with streptozotocin-induced diabetes mellitus. Oh JE; Jun JH; Hwang HJ; Shin EJ; Oh YJ; Choi YS Acta Diabetol; 2019 Jan; 56(1):105-114. PubMed ID: 30206697 [TBL] [Abstract][Full Text] [Related]
5. Insulin replacement limits progression of diabetic cardiomyopathy in the low-dose streptozotocin-induced diabetic rat. Tate M; Deo M; Cao AH; Hood SG; Huynh K; Kiriazis H; Du XJ; Julius TL; Figtree GA; Dusting GJ; Kaye DM; Ritchie RH Diab Vasc Dis Res; 2017 Sep; 14(5):423-433. PubMed ID: 28565941 [TBL] [Abstract][Full Text] [Related]
6. NADPH oxidase inhibitor apocynin prevents atrial remodeling in alloxan-induced diabetic rabbits. Qiu J; Zhao J; Li J; Liang X; Yang Y; Zhang Z; Zhang X; Fu H; Korantzopoulos P; Liu T; Li G Int J Cardiol; 2016 Oct; 221():812-9. PubMed ID: 27434350 [TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase inhibitor, apocynin, restores the impaired endothelial-dependent and -independent responses and scavenges superoxide anion in rats with type 2 diabetes complicated by NO dysfunction. Hayashi T; Juliet PA; Kano-Hayashi H; Tsunekawa T; Dingqunfang D; Sumi D; Matsui-Hirai H; Fukatsu A; Iguchi A Diabetes Obes Metab; 2005 Jul; 7(4):334-43. PubMed ID: 15955119 [TBL] [Abstract][Full Text] [Related]
8. Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature. Shida T; Nozawa T; Sobajima M; Ihori H; Matsuki A; Inoue H Heart Vessels; 2014 Jul; 29(4):532-41. PubMed ID: 23979266 [TBL] [Abstract][Full Text] [Related]
9. Apocynin attenuates left ventricular remodeling in diabetic rabbits. Qiu J; Zhao J; Li J; Liang X; Yang Y; Zhang Z; Zhang X; Fu H; Korantzopoulos P; Tse G; Liu T; Li G Oncotarget; 2017 Jun; 8(24):38482-38490. PubMed ID: 28388570 [TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus activates fetal gene program and intensifies cardiac remodeling and oxidative stress in aged spontaneously hypertensive rats. Rosa CM; Xavier NP; Henrique Campos D; Fernandes AA; Cezar MD; Martinez PF; Cicogna AC; Gimenes C; Gimenes R; Okoshi MP; Okoshi K Cardiovasc Diabetol; 2013 Oct; 12():152. PubMed ID: 24134628 [TBL] [Abstract][Full Text] [Related]
11. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo. Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497 [TBL] [Abstract][Full Text] [Related]
12. PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes. Liu Y; Lei S; Gao X; Mao X; Wang T; Wong GT; Vanhoutte PM; Irwin MG; Xia Z Clin Sci (Lond); 2012 Feb; 122(4):161-73. PubMed ID: 21892921 [TBL] [Abstract][Full Text] [Related]
13. Antifibrotic cardioprotection of berberine via downregulating myocardial IGF-1 receptor-regulated MMP-2/MMP-9 expression in diabetic rats. Li G; Xing W; Zhang M; Geng F; Yang H; Zhang H; Zhang X; Li J; Dong L; Gao F Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H802-H813. PubMed ID: 29957017 [TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide 3-kinase (p110α) gene delivery limits diabetes-induced cardiac NADPH oxidase and cardiomyopathy in a mouse model with established diastolic dysfunction. Prakoso D; De Blasio MJ; Qin C; Rosli S; Kiriazis H; Qian H; Du XJ; Weeks KL; Gregorevic P; McMullen JR; Ritchie RH Clin Sci (Lond); 2017 Jun; 131(12):1345-1360. PubMed ID: 28487469 [TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes. Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of human C-reactive protein exacerbates left ventricular remodeling in diabetic cardiomyopathy. Mano Y; Anzai T; Kaneko H; Nagatomo Y; Nagai T; Anzai A; Maekawa Y; Takahashi T; Meguro T; Yoshikawa T; Fukuda K Circ J; 2011; 75(7):1717-27. PubMed ID: 21519150 [TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. Dong B; Yu QT; Dai HY; Gao YY; Zhou ZL; Zhang L; Jiang H; Gao F; Li SY; Zhang YH; Bian HJ; Liu CX; Wang N; Xu H; Pan CM; Song HD; Zhang C; Zhang Y J Am Coll Cardiol; 2012 Feb; 59(8):739-47. PubMed ID: 22340266 [TBL] [Abstract][Full Text] [Related]
20. Activation of NADPH oxidase mediates mitochondrial oxidative stress and atrial remodeling in diabetic rabbits. Zhou L; Liu Y; Wang Z; Liu D; Xie B; Zhang Y; Yuan M; Tse G; Li G; Xu G; Liu T Life Sci; 2021 May; 272():119240. PubMed ID: 33600862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]